Actively Recruiting

Phase Not Applicable
Age: 20Years +
All Genders
NCT05566353

Telemonitoring in Cochlear Implant Patient Care

Led by University Hospital, Montpellier · Updated on 2024-05-28

78

Participants Needed

1

Research Sites

130 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Montpellier

Lead Sponsor

U

University Hospital, Toulouse

Collaborating Sponsor

AI-Summary

What this Trial Is About

Following a sufficient delay after the cochlear implantation and initial implant activation, the patient will return to the hospital for follow-up visits for equipment maintenance and auditory performance evaluation only once per year. This frequency might appear either insufficient, in which case an additional patient check-up will be arranged, or excessive if patient performances and implant adjustments are stable. Using at-home testing tool for remote hearing performance monitoring can thus appear advantageous for both patients and clinicians, allowing to avoid an unnecessary journey to the implantation reference center for the first and to diminish a number of unscheduled medical appointments for the second.

CONDITIONS

Official Title

Telemonitoring in Cochlear Implant Patient Care

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Users of uni- or bilateral cochlear implants (Cl24RE series 400, 500, 600) and Cochlear Nucleus CP1000 or CP1150 processors for at least one year
  • Have renewed their processor at least once
  • Implanted for more than 5 years
  • Age over 20 years
  • Own Apple or Android smartphones compatible with Remote Check application
Not Eligible

You will not qualify if you...

  • Physical (visual, motor) or severe cognitive impairments preventing use of smartphone software and hearing tests
  • Unable to give oral informed consent
  • Living in areas with limited internet access
  • Legally deprived of liberty by judicial or administrative decision
  • Under legal protection measures (guardianship or curatorship)
  • French is not the native language

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Montpellier

Montpellier, France

Actively Recruiting

Loading map...

Research Team

F

Frédéric Venail, PhD, MD

CONTACT

O

Olivier Deguine, PhD, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here